Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 121
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody...

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Will vitamin D improve the health of patients with heart failure?

We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function...

Backer Badge Funded